PANDA Therapeutics secures €160K to advance multi-target Alzheimer’s therapy
Tech.eu 1 month ago 3
PANDA Therapeutics secured €160,000 from Venture Kick to move a multi-target Alzheimer’s therapy toward clinical development. The funding amount is €160,000 (CHF 150,000). It will be used for company formation and business development, including building advisory and CMC/manufacturing readiness plans, plus IP and regulatory planning for later financing and partnerships.